Alpha connexin C-terminal (ACT) peptides for use in transplant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9844214
SERIAL NO

15195569

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MUSC FOUNDATION FOR RESEARCH DEVELOPMENT19 HAGOOD AVENUE SUITE 909 CHARLESTON SC 29425

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ghatnekar, Gautam Charleston, US 23 299
Gourdie, Robert Charleston, US 11 244
Jourdan, Jane Charleston, US 9 214

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00